2Almeida M,Ana V,Sapolnik R,et al. New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients [ J ]. J Pediatr, 2007,83 (2) : 54 - 63.
3Roland AA, Nicole B, Andreas H, et al.Predicting adverse events in children with fever and chemotherapy- induced neutropenia:the prospective multicenter SPOG 2003 FN study[J]. J Clin Oncol, 2010,28(12) : 2 008-2 014.
4Asturias E J, Corral JE, Quezada J.Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia[ J ]. Curr Oncol, 201 0, 17 (2) : 59 - 63.
5Thomas L, Hans JL, Aleandra B, et al. Compliance with anti-itffee- rive preventive measures:a muhicenter survey among paediatric on- cology patients[ J ].Eur J Cancer, 2008,44( 13 ) : 1 861 - 1 865.
6Sinead K, Felicity H, Hugh M. Consulting the oracle:ten lessons from us- ing the Delphi technique in nursing research [ J ].J JAdv Nut, 2006,53 (2):205-212.
7Dionissios N,Kit Lu,Amy H,et al. Epidemiology,outcomes,and risk factors of invasive fungal infections in adult patients with acute mydoge- nous leukemia after induction chemotherapy[ J ]. Diagn Microbiol Infect Dis,2013,75(2): 144-149.
8Paula P, Lficia S, Caroline M, et al. Effectiveness of a protective environ- ment implementation for cancer patients with chemotherapyinduced neu- tropenia on fever and mortality incidence[J].Am J Infect Conn1, 2013,41(4) :357-359.
9Lalla RV,Saunders DP,Peterson DE.Chemotherapy or radiation- in- duced oral mucositis[ J ].Dent Clin North Am, 2014,58 (2) : 341-349.
